PDB Short entry for 5EGU HEADER TRANSCRIPTION 27-OCT-15 5EGU TITLE FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR 3- TITLE 2 BUTYL-8-(6-BUTYL-5,7-DIMETHYL-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-2- TITLE 3 YLSULFANYLMETHYL)-7-ETHYL-3,7-DIHYDROPURINE-2,6-DIONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: N-TERMINAL BROMODOMAIN, RESIDUES 42-168; COMPND 5 SYNONYM: PROTEIN HUNK1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDEST17 KEYWDS INHIBITOR, HISTONE, EPIGENETIC READER, BROMODOMAIN, BRD4, BRD4_BD1, KEYWDS 2 BRD4_BD1 06-NOV, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR B.RAUX,E.REBUFFET,S.BETZI,S.PRIET,X.MORELLI REVDAT 3 10-JAN-24 5EGU 1 REMARK REVDAT 2 09-MAR-16 5EGU 1 JRNL REVDAT 1 20-JAN-16 5EGU 0 JRNL AUTH B.RAUX,Y.VOITOVICH,C.DERVIAUX,A.LUGARI,E.REBUFFET,S.MILHAS, JRNL AUTH 2 S.PRIET,T.ROUX,E.TRINQUET,J.C.GUILLEMOT,S.KNAPP,J.M.BRUNEL, JRNL AUTH 3 A.Y.FEDOROV,Y.COLLETTE,P.ROCHE,S.BETZI,S.COMBES,X.MORELLI JRNL TITL EXPLORING SELECTIVE INHIBITION OF THE FIRST BROMODOMAIN OF JRNL TITL 2 THE HUMAN BROMODOMAIN AND EXTRA-TERMINAL DOMAIN (BET) JRNL TITL 3 PROTEINS. JRNL REF J.MED.CHEM. V. 59 1634 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26735842 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01708 REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0131 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 29752 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1566 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.21 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.27 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2077 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.22 REMARK 3 BIN R VALUE (WORKING SET) : 0.2060 REMARK 3 BIN FREE R VALUE SET COUNT : 109 REMARK 3 BIN FREE R VALUE : 0.2670 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3934 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 140 REMARK 3 SOLVENT ATOMS : 250 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.39000 REMARK 3 B22 (A**2) : 0.67000 REMARK 3 B33 (A**2) : -1.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.247 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.203 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.130 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.087 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4193 ; 0.018 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 4001 ; 0.006 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5708 ; 1.832 ; 2.003 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9216 ; 1.289 ; 3.006 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 464 ; 6.442 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 201 ;36.462 ;25.821 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 729 ;14.214 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;14.513 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 591 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4640 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 950 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1871 ; 2.154 ; 2.292 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1870 ; 2.151 ; 2.290 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2330 ; 3.246 ; 3.407 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2331 ; 3.246 ; 3.410 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2322 ; 2.700 ; 2.561 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2322 ; 2.699 ; 2.561 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3379 ; 4.270 ; 3.716 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5421 ; 5.644 ;18.646 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5421 ; 5.644 ;18.648 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5EGU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1000214894. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-NOV-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.541790 REMARK 200 MONOCHROMATOR : M REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 17 JUN 2015 REMARK 200 DATA SCALING SOFTWARE : XDS 17 JUN 2015 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59187 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 4.630 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.1500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.21 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.52 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.440 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: 2OSS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RATIO 1:1 (PROTEIN:PRECIPITANT). 25 REMARK 280 MG/ML BRD4_BD1 PROTEIN. 1.0 MM INHIBITOR (IN DMSO) FINAL REMARK 280 CONCENTRATION. PROTEIN BUFFER: 0.01M HEPES (PH 7.5), 0.15M NACL. REMARK 280 PRECIPITANT AGENT : 0.2M AMMONIUM SULFATE, 0.1M TRIS PH 8.5, 25% REMARK 280 PEG3350. CRYOPROTECTANT : 10% ETHYLENE GLYCOL., VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.84300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.69550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.80600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.69550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.84300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.80600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 42 REMARK 465 MET A 43 REMARK 465 LYS A 55 REMARK 465 PRO A 56 REMARK 465 LYS A 57 REMARK 465 GLU A 168 REMARK 465 SER B 42 REMARK 465 MET B 43 REMARK 465 ASN B 44 REMARK 465 PRO B 45 REMARK 465 PRO B 46 REMARK 465 PRO B 47 REMARK 465 PRO B 48 REMARK 465 GLU B 49 REMARK 465 THR B 50 REMARK 465 SER B 51 REMARK 465 ASN B 52 REMARK 465 SER C 42 REMARK 465 MET C 43 REMARK 465 ASN C 44 REMARK 465 PRO C 45 REMARK 465 PRO C 46 REMARK 465 PRO C 47 REMARK 465 PRO C 48 REMARK 465 GLU C 49 REMARK 465 THR C 50 REMARK 465 SER C 51 REMARK 465 ASN C 52 REMARK 465 PRO C 53 REMARK 465 ASN C 54 REMARK 465 LYS C 55 REMARK 465 PRO C 56 REMARK 465 LYS C 57 REMARK 465 ARG C 58 REMARK 465 GLN C 59 REMARK 465 GLU C 168 REMARK 465 SER D 42 REMARK 465 GLU D 167 REMARK 465 GLU D 168 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 44 CG OD1 ND2 REMARK 470 ARG A 58 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 93 64.45 61.34 REMARK 500 THR A 103 76.26 -119.10 REMARK 500 GLN B 59 63.10 62.30 REMARK 500 ASN C 140 -169.38 -107.37 REMARK 500 THR D 103 75.32 -117.11 REMARK 500 PRO D 165 -71.92 -59.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5NQ A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5NQ B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5NQ C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5NQ D 201 DBREF 5EGU A 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 5EGU B 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 5EGU C 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 5EGU D 44 168 UNP O60885 BRD4_HUMAN 44 168 SEQADV 5EGU SER A 42 UNP O60885 EXPRESSION TAG SEQADV 5EGU MET A 43 UNP O60885 EXPRESSION TAG SEQADV 5EGU SER B 42 UNP O60885 EXPRESSION TAG SEQADV 5EGU MET B 43 UNP O60885 EXPRESSION TAG SEQADV 5EGU SER C 42 UNP O60885 EXPRESSION TAG SEQADV 5EGU MET C 43 UNP O60885 EXPRESSION TAG SEQADV 5EGU SER D 42 UNP O60885 EXPRESSION TAG SEQADV 5EGU MET D 43 UNP O60885 EXPRESSION TAG SEQRES 1 A 127 SER MET ASN PRO PRO PRO PRO GLU THR SER ASN PRO ASN SEQRES 2 A 127 LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU LEU SEQRES 3 A 127 ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE ALA SEQRES 4 A 127 TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU ASN SEQRES 5 A 127 LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET ASP SEQRES 6 A 127 MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR TYR SEQRES 7 A 127 TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR MET SEQRES 8 A 127 PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP ASP SEQRES 9 A 127 ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE LEU SEQRES 10 A 127 GLN LYS ILE ASN GLU LEU PRO THR GLU GLU SEQRES 1 B 127 SER MET ASN PRO PRO PRO PRO GLU THR SER ASN PRO ASN SEQRES 2 B 127 LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU LEU SEQRES 3 B 127 ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE ALA SEQRES 4 B 127 TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU ASN SEQRES 5 B 127 LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET ASP SEQRES 6 B 127 MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR TYR SEQRES 7 B 127 TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR MET SEQRES 8 B 127 PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP ASP SEQRES 9 B 127 ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE LEU SEQRES 10 B 127 GLN LYS ILE ASN GLU LEU PRO THR GLU GLU SEQRES 1 C 127 SER MET ASN PRO PRO PRO PRO GLU THR SER ASN PRO ASN SEQRES 2 C 127 LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU LEU SEQRES 3 C 127 ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE ALA SEQRES 4 C 127 TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU ASN SEQRES 5 C 127 LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET ASP SEQRES 6 C 127 MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR TYR SEQRES 7 C 127 TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR MET SEQRES 8 C 127 PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP ASP SEQRES 9 C 127 ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE LEU SEQRES 10 C 127 GLN LYS ILE ASN GLU LEU PRO THR GLU GLU SEQRES 1 D 127 SER MET ASN PRO PRO PRO PRO GLU THR SER ASN PRO ASN SEQRES 2 D 127 LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU LEU SEQRES 3 D 127 ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE ALA SEQRES 4 D 127 TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU ASN SEQRES 5 D 127 LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET ASP SEQRES 6 D 127 MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR TYR SEQRES 7 D 127 TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR MET SEQRES 8 D 127 PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP ASP SEQRES 9 D 127 ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE LEU SEQRES 10 D 127 GLN LYS ILE ASN GLU LEU PRO THR GLU GLU HET 5NQ A 201 34 HET EDO A 202 4 HET 5NQ B 201 34 HET 5NQ C 201 34 HET 5NQ D 201 34 HETNAM 5NQ 3-BUTYL-8-[(6-BUTYL-5,7-DIMETHYL-[1,2,4]TRIAZOLO[1,5- HETNAM 2 5NQ A]PYRIMIDIN-2-YL)SULFANYLMETHYL]-7-ETHYL-PURINE-2,6- HETNAM 3 5NQ DIONE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 5 5NQ 4(C23 H32 N8 O2 S) FORMUL 6 EDO C2 H6 O2 FORMUL 10 HOH *250(H2 O) HELIX 1 AA1 GLN A 59 VAL A 69 1 11 HELIX 2 AA2 VAL A 69 HIS A 77 1 9 HELIX 3 AA3 ALA A 80 GLN A 84 5 5 HELIX 4 AA4 ASP A 96 ILE A 101 1 6 HELIX 5 AA5 ASP A 106 ASN A 117 1 12 HELIX 6 AA6 ASN A 121 ASN A 140 1 20 HELIX 7 AA7 ASP A 144 GLU A 163 1 20 HELIX 8 AA8 GLN B 59 VAL B 69 1 11 HELIX 9 AA9 VAL B 69 HIS B 77 1 9 HELIX 10 AB1 ALA B 80 GLN B 84 5 5 HELIX 11 AB2 ASP B 96 ILE B 101 1 6 HELIX 12 AB3 ASP B 106 ASN B 116 1 11 HELIX 13 AB4 ASN B 121 ASN B 140 1 20 HELIX 14 AB5 ASP B 144 ASN B 162 1 19 HELIX 15 AB6 ASN C 61 VAL C 69 1 9 HELIX 16 AB7 VAL C 69 HIS C 77 1 9 HELIX 17 AB8 ALA C 80 GLN C 84 5 5 HELIX 18 AB9 ASP C 96 ILE C 101 1 6 HELIX 19 AC1 ASP C 106 ASN C 116 1 11 HELIX 20 AC2 ASN C 121 ASN C 140 1 20 HELIX 21 AC3 ASP C 144 GLU C 163 1 20 HELIX 22 AC4 THR D 60 VAL D 69 1 10 HELIX 23 AC5 VAL D 69 HIS D 77 1 9 HELIX 24 AC6 ALA D 80 GLN D 84 5 5 HELIX 25 AC7 ASP D 96 ILE D 101 1 6 HELIX 26 AC8 ASP D 106 ASN D 116 1 11 HELIX 27 AC9 ASN D 121 ASN D 140 1 20 HELIX 28 AD1 ASP D 144 ASN D 162 1 19 SITE 1 AC1 12 PRO A 82 PHE A 83 GLN A 85 PRO A 86 SITE 2 AC1 12 VAL A 87 ASP A 88 LEU A 92 LEU A 94 SITE 3 AC1 12 ASN A 140 HOH A 309 HOH A 312 5NQ D 201 SITE 1 AC2 3 PRO A 86 LYS A 112 HOH A 310 SITE 1 AC3 13 PRO B 82 PHE B 83 GLN B 85 VAL B 87 SITE 2 AC3 13 ASP B 88 LEU B 92 LEU B 94 ASN B 140 SITE 3 AC3 13 HOH B 306 HOH B 313 HOH B 324 LYS C 91 SITE 4 AC3 13 MET C 149 SITE 1 AC4 13 TRP B 81 MET B 149 PRO C 82 PHE C 83 SITE 2 AC4 13 GLN C 85 VAL C 87 ASP C 88 LYS C 91 SITE 3 AC4 13 LEU C 92 LEU C 94 ASN C 140 ILE C 146 SITE 4 AC4 13 HOH C 311 SITE 1 AC5 12 MET A 149 5NQ A 201 PRO D 82 PHE D 83 SITE 2 AC5 12 GLN D 85 VAL D 87 ASP D 88 LEU D 92 SITE 3 AC5 12 LEU D 94 ASN D 140 HOH D 306 HOH D 320 CRYST1 69.686 83.612 107.391 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014350 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011960 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009312 0.00000